FAST-FFR Pivotal Trial

92% Diagnostic Accuracy, 94% Sensitivity, and 91% Specificity

The FAST-FFR pivotal trial was a prospective multicenter, international trial designed to determine the accuracy of FFRangio in clinical practice compared to traditional wire-based FFR. The trial included 301 patients and 319 vessels at 10 clinical sites. The results demonstrated excellent diagnostic performance, including in the grey zone between FFR values of 0.75 and 0.85.

Contact CathWorks Today